SoCal.StartupsBe an early user

Rejuvenate Bio Inc

San Diego, CA
LAST FUNDING
$19.5M
Series A

Funding history

DateRoundAmountInvestorsSource
Series A$19.5M

About Rejuvenate Bio Inc

How much funding has Rejuvenate Bio Inc raised?

Rejuvenate Bio Inc has raised $19.5M in total funding. The most recent round was Series A.

Where is Rejuvenate Bio Inc headquartered?

Rejuvenate Bio Inc is headquartered in San Diego, CA.

What problem does Rejuvenate Bio Inc solve?

Chronic, age-related diseases such as osteoarthritis, heart disease, and cancer are described as the primary threat to longevity and quality of life in aging dogs, and the page notes six in ten Americans live with at least one chronic disease, a leading cause of death, disability, and healthcare cost.

What's Rejuvenate Bio Inc's solution?

Rejuvenate Bio develops gene therapies aimed at the root causes of aging to treat chronic conditions in both companion animals and humans.

What makes Rejuvenate Bio Inc different?

The company is running trials in dogs (MVD Trial 2020 and MVD Trial 2026) as part of its approach, using naturally aging companion animals as part of its pipeline toward human treatments.

Leadership

Noah Davidsohn
Executive Officer, Director
LinkedIn ↗
Daniel Oliver
Executive Officer, Director
LinkedIn ↗
David Zhu
Director
❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.

MLA
"Rejuvenate Bio Inc: Funding & Investors." SoCal.Startups, August 27, 2026, https://socalstartups.io/companies/city/san-diego/healthcare/rejuvenate-bio-inc. Accessed August 27, 2026.
APA
SoCal.Startups. (2026). Rejuvenate Bio Inc: Funding & Investors. Retrieved August 27, 2026, from https://socalstartups.io/companies/city/san-diego/healthcare/rejuvenate-bio-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=Rejuvenate Bio Inc: Funding & Investors |url=https://socalstartups.io/companies/city/san-diego/healthcare/rejuvenate-bio-inc |website=SoCal.Startups |access-date=August 27, 2026}}